Clinical Trials Browser

Phase 3 × Carcinoma, Hepatocellular × contrast agent BR1 × Clear all

NCT04006275 2019-09-19

Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCC

Phase 3 Unknown

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular